The Trust Research, Development, and Innovation (RD&I) Integrated Performance Report summarises and provides an update of activities of the Trust’s RD&I service for each quarter of the financial year.
The report reflects the RD&I strategic priorities published in the Velindre University NHS Trust’s Integrated Medium-Term Plan (IMTP). These priorities support the Trust’s strategic goal to be “A beacon for research, development and innovation” are as follows:
Strategic Priorities |
|
|
Priority 1 |
The Trust will drive forward the implementation of its Cancer Research and Development Ambitions 2022-2031. |
|
Priority 2 |
The Trust will maximise the Research and Development ambitions of the Welsh Blood Service. |
|
Priority 3 |
The Trust will implement the Velindre Innovation Plan. |
|
Priority 4 |
The Trust will maximise collaborative opportunities locally, nationally, and internationally. |
The report provides an update of activities against the Trust RD&I service’s strategic priorities, alongside the supporting work of cross‑cutting themes and corporate functions that support research, development, and innovation.